These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cancer's orphan generation. Medical experts increase the survival rates of teens and young adults. Hobson K US News World Rep; 2007 Jan; 142(2):76-7. PubMed ID: 17225472 [No Abstract] [Full Text] [Related]
4. Data sphere shares clinical trial information. Cancer Discov; 2012 Dec; 2(12):1072. PubMed ID: 23230173 [TBL] [Abstract][Full Text] [Related]
5. Trigger found that may start cancer's spread. Research may lead to new therapies to halt cancer's progression. Duke Med Health News; 2010 May; 16(5):1-2. PubMed ID: 20518130 [No Abstract] [Full Text] [Related]
7. Seeing the signs of cancer's metabolic changes: More and more, researchers are visualizing metabolic markers to provide details regarding how cancer cells react to changing conditions and treatments. Nelson B Cancer Cytopathol; 2019 Feb; 127(2):67-68. PubMed ID: 30762975 [No Abstract] [Full Text] [Related]
9. In vitro drug response assays for entry into the rational era cancer chemotherapy. Hoffman RM Hum Cell; 1995 Dec; 8(4):131-48. PubMed ID: 8721082 [No Abstract] [Full Text] [Related]
10. Perspective: Finding cancer's first principles. Gatenby R Nature; 2012 Nov; 491(7425):S55. PubMed ID: 23320287 [No Abstract] [Full Text] [Related]
11. New targets for cancer chemotherapy. Murgo AJ; Dancey J; Eckhardt SG; Hidalgo M; Arbuck SG; Zerivitz K; Blaylock BA Cancer Chemother Biol Response Modif; 2002; 20():239-72. PubMed ID: 12703208 [No Abstract] [Full Text] [Related]
12. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic? Roukos DH Expert Rev Proteomics; 2012 Aug; 9(4):349-53. PubMed ID: 22967071 [No Abstract] [Full Text] [Related]
14. Biologists take degrading route to tackle cancer. Abbott A Nature; 2004 Jun; 429(6994):794. PubMed ID: 15215827 [No Abstract] [Full Text] [Related]
15. Cancer's big sleep: senescence may be potential target for cancer therapies. Erdmann J J Natl Cancer Inst; 2005 Jan; 97(2):89-91. PubMed ID: 15657336 [No Abstract] [Full Text] [Related]
19. The lessons of failure: clinical flops are helping researchers define the keys to successful cancer drug trials. Nelson B Cancer Cytopathol; 2012 Dec; 120(6):359-60. PubMed ID: 23242934 [No Abstract] [Full Text] [Related]
20. Revelation that needs to be espoused in regards to the exact reason for cancer's origin, it's growth, spread, and pathological consequences. White MW Exp Biol Med (Maywood); 2002 Jun; 227(6):432-3. PubMed ID: 12037133 [No Abstract] [Full Text] [Related] [Next] [New Search]